Pharmacokinetic-Pharmacodynamic Evaluation of Gepotidacin against Gram-Positive Organisms Using Data from Murine Infection Models

Gepotidacin (formerly called GSK2140944) is a novel triazaacenaphthylene bacterial topoisomerase inhibitor with in vitro activity against conventional and biothreat pathogens, including Staphylococcus aureus and Streptococcus pneumoniae. Using neutropenic murine thigh and lung infection models, the...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Antimicrob Agents Chemother
Glavni autori: Bulik, Catharine C., Okusanya, Ólanrewaju O., Lakota, Elizabeth A., Forrest, Alan, Bhavnani, Sujata M., Hoover, Jennifer L., Andes, David R., Ambrose, Paul G.
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology 2017
Teme:
Experimental Therapeutics
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5278741/
https://ncbi.nlm.nih.gov/pubmed/27872075
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00115-16
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items